RNAZ
TransCode Therapeutics, Inc. Common Stock
stockNASDAQ
At CloseOct 20, 2026 3:30:03 PM EDT
1.67USD-1.765%(-0.03)19,929
Loading…
Loading…
28.44M
Healthcare
Biotechnology
HQ
Boston, MA, USA
Previous Close
$1.70
Beta
1.05
52-Week High
$15.33 2025-10-20
52-Week Low
$1.52 2026-10-01
SMA 50
$2.13
SMA 200
$6.41
Avg. Vol 10D
41,227
Avg. Vol 30D
47,222
Avg. Vol 90D
45,768
Relative Vol
0.41
16.93M
965,708
5.70%
52,062
5.39%
1.00
45%/55%
63.88%
44.87%
8.5100%
80,000
463
3,744
18,108
Nov 13, 2026 (24d)
May 15, 2025 · 1-for-28 (reverse)
-42.8M
-51.18
Oct 19, 2026
Oct 1, 2026
Sep 22, 2026
Sep 16, 2026
RNAZ Profile
transcode therapeutics is a boston based pre-clinical biopharmaceutical company focused on discovery, development and commercialization of a pipeline of innovative microrna (mirnas or mirs) therapeutics for treating metastatic disease.
RNAZ Performance
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1M | 1.76 | 2026-09-21 | -4.54% | 4.086 |
| 3M | 8.73 | 2026-07-20 | -80.76% | 2.887 |
| 6M | 8.89 | 2026-04-20 | -81.09% | 1.539 |
| 1Y | 14.76 | 2025-10-20 | -88.62% | 1.047 |
| 2Y | 568.26 | 2024-10-21 | -99.70% | — |
| 5Y | 2,202,816.00 | 2021-10-20 | -100.00% | 0.209 |
RNAZ Stock Summary
TransCode Therapeutics, Inc. Common Stock (NASDAQ:RNAZ) stock price today is $1.68, and today's volume is 19,553. RNAZ is down 1.176% today. The 30 day average volume is 47,222. RNAZ market cap is $28.44M with 16.93M shares outstanding.